BC
Brad Canino Credit Suisse Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Oric Pharmaceuticals
ORIC
$1.02B
| $10.91 | $18 |
65%
upside
| Buy |
4 Sep ‘25
6 days ago |
|
2
Relay Therapeutics
RLAY
$702M
| $4.07 | $15 |
269%
upside
| Buy |
4 Sep ‘25
6 days ago |
|
3
Nuvalent
NUVL
$5.76B
| $78.73 | $122 |
55%
upside
| Buy |
4 Sep ‘25
6 days ago |
|
4
C4 Therapeutics
CCCC
$191M
| $2.68 | $8 |
199%
upside
| Buy |
4 Sep ‘25
6 days ago |
|
5
Janux Therapeutics
JANX
$1.43B
| $23.78 | $72 |
203%
upside
| Buy |
4 Sep ‘25
6 days ago |
|
6
Black Diamond Therapeutics
BDTX
$185M
| $3.25 | $8 |
146%
upside
| Buy |
4 Sep ‘25
6 days ago |
|
7
Summit Therapeutics
SMMT
$14B
| $18.82 | $40 |
113%
upside
| Buy |
4 Sep ‘25
6 days ago |
|
8
Pyxis Oncology
PYXS
$113M
| $1.83 | $5 |
173%
upside
| Buy |
4 Sep ‘25
6 days ago |
|
9
Mersana Therapeutics
MRSN
$35.1M
| $7.66 | $450 |
5,775%
upside
| Neutral |
31 Mar ‘21
4 years ago |
|
10
Zymeworks
ZYME
$1.15B
| $15.23 | $55 |
261%
upside
| Outperform |
31 Mar ‘21
4 years ago |
|
11
Exelixis
EXEL
$10.3B
| $38.28 | $30 |
22%
downside
| Outperform |
31 Mar ‘21
4 years ago |
|